Up next

Autoplay

Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma

0 Views • 07/18/23
Share
Embed
administrator
administrator
Subscribers
0

The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay